Updated Jul 16, 2026
Bashan Dror is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Dror Bashan is the President and CEO of Protalix BioTherapeutics, Inc., a biopharmaceutical company specializing in recombinant therapeutic proteins. Under his leadership, the company has focused on developing treatments for rare diseases, including Gaucher disease.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-09-03 | PLX | Protalix BioTherapeutics, Inc. | A — Grant or award | 195.0K | — |
Dror Bashan is the President and CEO of Protalix BioTherapeutics, Inc., a biopharmaceutical company specializing in recombinant therapeutic proteins. Under his leadership, the company has focused on developing treatments for rare diseases, including Gaucher disease.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Bashan Dror profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.